Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents

Published:2020-12 Issue: Volume:105 Page:104424
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Xu Chenhao,Zhou Wenjuan,Dong Guanjun,Qiao Hui,Peng Jiadi,Jia Pengfei,Li Yuhao,Liu Hongmin,Sun Kai,Zhao Wen

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference39 articles.

1. Cancer Research for Cancer Prevention;World Cancer Report,2020

2. Cancer statistics;Siegel;CA Cancer J. Clin.,2020

3. New hope in prostate cancer precision medicine? miRNA replacement and epigenetics;Bjartell;Clin. Cancer Res.,2019

4. Cancer statistics;Siegel;CA Cancer J. Clin.,2019

5. Extracellular purines, purinergic receptors and tumor growth;Di Virgilio;Oncogene,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrazide-hydrazone/hydrazone as enabling linkers in anti-cancer drug discovery: A comprehensive review;Journal of Molecular Structure;2024-07

2. Novel pyrazole-4-carboxamides and aromatic carboxamides derivatives containing a hydrazine moiety as potential SDHIs;Journal of Molecular Structure;2023-11

3. Recent advances of LSD1/KDM1A inhibitors for disease therapy;Bioorganic Chemistry;2023-05

4. Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects;ChemistrySelect;2022-12-08

5. Prediction of Anti-proliferation Effect of [1,2,3]Triazolo[4,5-<i>d</i>]pyrimidine Derivatives by Random Forest and Mix-Kernel Function SVM with PSO;Chemical and Pharmaceutical Bulletin;2022-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3